Incidence and risk factors for the metabolic syndrome in an urban South European population

Preventive Medicine

Volumn 50, Issue 3, 2010, Pages 99-105

  Santos, Ana Cristina ^a   Severo, Milton ^a   Barros, Henrique ^a  

^a University of Porto   (Portugal)

Author keywords

Incidence; Metabolic syndrome X; Obesity; Portugal

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CALORIC INTAKE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EUROPE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; COHORT STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POISSON DISTRIBUTION; PORTUGAL; QUESTIONNAIRES; RISK FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 77149172047     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2009.11.011     Document Type: Article

References (52)

1. Allain C., Poon L., Chan C., et al. Enzimatic determination of total serum cholesterol. Clin. Chem. 1974, 20:470-475.
2. Arnold R., Ranchor A.V., Sanderman R., Kempen G.I., Ormel J., Suurmeijer T.P. The relative contribution of domains of quality of life to overall quality of life for different chronic diseases. Qual. Life Res. 2004, 13:883-896.
3. Balkau B., Vernay M., Mhamdi L., Novak M., Arondel D., Vol S., Tichet J., Eschwège E., Group D.S. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French DESIR study. Diabetes Metab. 2003, 29:526-532.
4. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
5. Bland M. Mortality statistics and population structure. An Introduction to Medical Statistics 1995, 291-305. Oxford Univ. Press, Oxford. 2nd ed.
6. Bucolo G., David H. Quantitative determination of serum triglycerides by use of enzymes. Clin. Chem. 1973, 19:476-482.
7. Cameron A.J., Shaw J.E., Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinol. Metab. Clin. North Am. 2004, 33:351-375.
8. Carnethon M.R., Loria C.M., Hill J.O., Sidney S., Savage P.J., Liu K. Risk factors for the metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 2004, 27:2707-2715.
9. Chedraui P., Hidalgo L., Chavez D., Morocho N., Alvarado M., Huc A. Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas 2007, 56:45-53.
10. de Castro J.J., Aleixo Dias J., Baptista F., Garcia e Costa J., Galvao-Teles A., Camilo-Alves A. Secular trends of weight, height and obesity in cohorts of young Portuguese males in the District of Lisbon: 1960-1990. Eur. J. Epidemiol. 1998, 14:299-303.
11. Comparison of three different definitions for the metabolic syndrome in non-diabetic Europeans. Br. J. Diabetes Vas. Dis. 2005, 5:161-168. DECODE Study Group.
12. Prevalence of the metabolic syndrome in populations of Asian origin. Comparison of the IDF definition with the NCEP definition. Diabetes Res. Clin. Pract. 2006, 49:2837-2846. DECODA Study Group.
13. Dekker J.M., Girman C.J., Rhodes T., Nijpels G., Stehouwer C.D., Bouter L.M., Heine R.J. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005, 112:666-673.
14. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
15. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults.
16. Ferreira P.L. Development of the Portuguese version of MOS SF-36. Part I. Cultural and linguistic adaptation. Acta Med. Port. 2000, 13:55-66.
17. Ferreira P.L. Development of the Portuguese version of MOS SF-36. Part II. Validation tests. Acta Med. Port. 2000, 13:119-127.
18. Fonseca V.A. The metabolic syndrome, hyperlipidemia, and insulin resistance. CLin. Cornerstone 2005, 7:61-72.
19. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28:1769-1778.
20. Gal D.L., Santos A.C., Barros H. Leisure-time versus full-day energy expenditure: a cross-sectional study of sedentarism in a Portuguese urban population. BMC Public Health 2005, 5:16.
21. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005, 112:2735-2752.
22. Haffner S.M., Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003, 108:1541-1545.
23. Han T.S., Williams K., Sattar N., Hunt K.J., Lean M.E.J., Haffner S.M. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obesity Res. 2002, 10:923-931.
24. Han T., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M., Haffner S. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002, 25:2016-2021.
25. Hosmer D.W., Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992, 3:452-456.
26. Jeppesen J., Hansen T.W., Rasmussen S., Ibsen H., Torp-Pedersen C., Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease. A population-based study. J. Am. Coll. Cardiol. 2007, 49:2112-2119.
27. Katzmarzyk P.T., Janssen I., Ross R., Church T.S., Blair S.N. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006, 29:404-409.
28. Laaksonen D., Lakka H., Salonen J., Niskanen L., Rauramaa R., Lakka T. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002, 25:1612-1618.
29. Lidfeldt J., Nyberg P., Nerbrand C., Samsioe G., Schersten B., Agardh C.D. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes. Metab. 2003, 5:106-112.
30. Lopes, C., 2000. Reproducibility and validation of a food-frequency questionnaire. In: Diet and Acute Myocardial Infarction: A Population-Based Case-Control Study. [PhD thesis]. University of Porto, pp. 79-115.
31. Lopes C., Aro A., Azevedo A., Ramos E., Barros H. Intake and adipose tissue composition of fatty acids and risk of myocardial infarction in a male Portuguese community sample. J. Am. Diet. Assoc. 2007, 107:276-286.
32. Lorenzo C., Okoloise M., Williams K., Stern M.P., Haffner S.M. The metabolic syndrome as predictor of type 2 diabetes: The San Antonio Heart Study. Diabetes Care 2003, 26:3153-3159.
33. Molarius A., Seidell J., Sans S., Tuomilehto J., Kuulasmaa K. Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am. J. Public Health 2000, 90:1260-1268.
34. Nakanishi N., Suzuki K., Tatara K. Serum {gamma}-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004, 27:1427-1432.
35. Palanippan L., Carnethon M., Wang Y., Hanley A., Fortmann S., Haffner S., Wagenknecht L. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004, 27:788-793.
36. Ramos E., Lopes C., Barros H. Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann. Epidemiol. 2004, 14:437-441.
37. Roriz-Cruz M., Rosset I., Wada T., Sakagami T., Ishine M., Roriz-Filho J.S., Cruz T.R.S., Rodrigues R.P., Resmini I., Sudoh S., Wakatsuki Y., Nakagawa M., Souza A.C., Kita T., Matsubayashi K. Stroke-independent association between metabolic syndrome and functional dependence, depression, and low quality of life in elderly community-dwelling Brazilian people. J. Am. Geriatr. Soc. 2007, 55:374-382.
38. Rothman K., Greenland S. Mordern Epidemiology 1998, Lippncott Williams and Wilkins, Philadelphia, PA.
39. Ryu S., Song J., Choi B.Y., Lee S.J., Kim W.S., Chang Y.S., Kim D.I., Suh B.S., Sung K.C. Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann. Epidemiol. 2007, 17:245-252.
40. Santos A.C., Barros H. Prevalence and determinants of obesity in an urban sample of Portuguese adults. Public Health 2003, 117:430-437.
41. Santos A.C., Ebrahim S., Barros H. Alcohol intake, smoking, sleeping hours, physical activity and the metabolic syndrome. Prev. Med. 2007, 44:328-334.
42. Santos A.C., Ebrahim S., Barros H. Gender, socio-economic status and metabolic syndrome in middle-aged and old adults. BMC Public Health 2008, 8:62.
43. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D., Haffner S., Isles C., Macfarlane P., Packard C., Cobbe S., Shepherd J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003, 108:414-419.
44. Seidell J. Obesity, insulin resistance and diabetes-a worldwide epidemic. Br. J. Nutr. 2000, 83:S5-S8.
45. Severo M., Santos A.C., Lopes C., Barros H. Fiabilidade e validade dos conceitos teóricos das dimensões de saúde física e mental da versão portuguesa do MOS SF-36. Acta Med. Port. 2006, 19:281-288.
46. Sheu W.H.H., Chuang S.Y., Lee W.J., Tsai S.T., Chou P., Chen C.H. Predictors of incident diabetes, metabolic syndrome in middle-aged adults: A 10-year follow-up study from Kinmen. Taiwan Diabetes Res. Clin. Pract. 2006, 74:162-168.
47. Tong J., Boyko E., Utzschneider K., McNeely M., Hayashi T., Carr D., Wallace T., Zraika S., Gerchman F., Leonetti D., Fujimoto W., Kahn S. Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans. Diabetologia 2007, 50:1156-1160.
48. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 1992, 30:473-483.
49. Wee H.L., Cheung Y.B., Li S.C., Fong K.Y., Thumboo J. The impact of diabetes mellitus and other chronic medical conditions on health-related quality of life: is the whole greater than the sum of its parts?. Health and Quality of Life Outcomes 2005, 3:2.
50. Wilsgaard T., Jacobsen B.K. Lifestyle factors and incident metabolic syndrome. The Tromsø study 1979-2001. Diabetes Res. Clin. Pract. 2007, 78:217-224.
51. Guidelines for ATC classification. Collaborating Centre for Drug Statistics Methodology 1990, World Health Organization, Nordic Council on Medicines. WHO, Olso.
52. Obesity: preventing and managing the global epidemic. World Health Organization 1997, World Health Organization, Geneva, Switzerland.